ASRS
TBPH icon

Arizona State Retirement System’s Theravance Biopharma TBPH Stock Holding History

Arizona State Retirement System’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$181K Buy
10,656
+218
+2% +$3.61K ﹤0.01% 1988
2026
Q1 		$169K Buy
+10,438
New +$185K ﹤0.01% 1945
2025
Q1 		– Sell
-10,649
Closed -$100K – 2145
2024
Q4 		$100K Buy
10,649
+146
+1% +$1.33K ﹤0.01% 2089
2024
Q3 		$84.7K Buy
10,503
+307
+3% +$2.66K ﹤0.01% 2127
2024
Q2 		$86.5K Sell
10,196
-68
-0.7% -$614 ﹤0.01% 2070
2024
Q1 		$92.1K Sell
10,264
-1,548
-13% -$14.3K ﹤0.01% 2088
2023
Q4 		$133K Sell
11,812
-2,177
-16% -$21.9K ﹤0.01% 2059
2023
Q3 		$121K Sell
13,989
-218
-2% -$2.1K ﹤0.01% 2040
2023
Q2 		$147K Sell
14,207
-433
-3% -$4.78K ﹤0.01% 2031
2023
Q1 		$159K Sell
14,640
-1,534
-9% -$16.2K ﹤0.01% 2003
2022
Q4 		$181K Buy
16,174
+661
+4% +$6.95K ﹤0.01% 1956
2022
Q3 		$157K Buy
15,513
+534
+4% +$5K ﹤0.01% 1978
2022
Q2 		$136K Buy
14,979
+38
+0.3% +$350 ﹤0.01% 2050
2022
Q1 		$143K Buy
14,941
+110
+0.7% +$1.08K ﹤0.01% 2088
2021
Q4 		$164K Buy
14,831
+126
+0.9% +$1.1K ﹤0.01% 2134
2021
Q3 		$109K Buy
14,705
+2,531
+21% +$28.3K ﹤0.01% 2168
2021
Q2 		$177K Sell
12,174
-864
-7% -$16.2K ﹤0.01% 2143
2021
Q1 		$266K Buy
13,038
+144
+1% +$2.74K ﹤0.01% 1881
2020
Q4 		$229K Sell
12,894
-431
-3% -$7.74K ﹤0.01% 1879
2020
Q3 		$197K Buy
13,325
+3,447
+35% +$64.6K ﹤0.01% 1785
2020
Q2 		$207K Sell
9,878
-116
-1% -$2.98K ﹤0.01% 1636
2020
Q1 		$231K Buy
+9,994
New +$250K ﹤0.01% 1440

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
ICM
Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Arizona State Retirement System's TBPH Position: Q2 2026 in Review

Arizona State Retirement System increased its Theravance Biopharma (TBPH) stake by 2.1% in Q2 2026, buying an estimated $3.61K and bringing the position to 10,656 shares worth $181K. The position accounts for ﹤0.01% of the portfolio, ranked #1988.

Arizona State Retirement System first reported a position in TBPH in Q1 2020 and has held it in 22 quarters since. The position peaked at $266K in Q1 2021. 181 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

  • Arizona State Retirement System held 10,656 shares of Theravance Biopharma worth $181K as of Q2 2026.
  • Arizona State Retirement System bought 218 Theravance Biopharma shares in Q2 2026, an estimated $3.61K.
  • Theravance Biopharma made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #1988 holding.
  • Arizona State Retirement System first reported a position in Theravance Biopharma in Q1 2020 and has held it in 22 quarters since.
  • Arizona State Retirement System's Theravance Biopharma position peaked at $266K in Q1 2021.
  • 181 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.